This opportunity is no longer accepting applications.
grant PAR-23-033

Integrated Preclinical / Clinical AIDS Vaccine Development Program (IPCAVD) (U19 Clinical Trial Not Allowed)

This grant opportunity aims to support the development of advanced HIV-1 vaccine candidates from pre-clinical stages to clinical testing. Funding will cover various aspects including technology transfer, immunogenicity studies, process development, manufacturing under CGMP conditions, quality assurance, and regulatory submissions. It involves collaboration with Pharma, Biotech, or Contract Man…

The purpose of this Funding Opportunity Announcement (FOA) is to support translation of advanced HIV-1 vaccine candidates from pre-clinical studies through different phases of process and product development, Current Good Manufacturing Practice (CGMP) manufacturing and regulatory filing to the p…

Funding Source

Agency: National Institutes of Health
Sub-agency: National Institute of Allergy and Infectious Diseases
Program: SBIR

Awards & funding

Award Ceiling: $3M
Award Amount: $3M

Dates

Application Window Closes: March 14, 2025
Opportunity Released: October 31, 2022
Open for Submission: October 31, 2022
Submission Deadline: March 14, 2025

Supporting links

Secure Grant Funding 10x Faster

Scout delivers AI-powered grant writing paired with experts that's faster, more affordable, and built to win.

Already have an account? Sign In

Trusted by 500+ Happy Customers

Get opportunities sent to your inbox

The latest grant news and insights from our experts.

Save this opportunity and explore more

Share Opportunity

Share this opportunity with others.
Anyone with this link can view the opportunity details.